The Latest Breaking News on Pharma

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

Despite lingering macro disruptions, Street analysts expect pharma stock Pfizer (PFE) to gain double digits in the near term. Moreover, it pays a reliable dividend. Given its robust fundamentals, I think PFE might be an ideal buy for the long haul. Keep reading.

CSL has beaten first-half earnings expectations thanks to its vaccine business and contributions from its new iron deficiency therapy company.

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…

163% more women would lose access to abortion care if the FDA's approval of mifepristone is revoked.

Big pharma has choices about where to make new investments and, increasingly it seems, it is not choosing Britain

More than 20 states are investigating or have investigated Centene’s Medicaid pharmacy billing. The company also has agreed to pay settlements to at least 16 other states, including Illinois and Indiana.

The national drug-buying agency will get an extra $66 million in 2023 in a one-off cash injection, according to documents reviewed by Newsroom.

The pharmaceuticals firm recently joined forced with Pennsylvania-based Viatris to tackle the American market